NAVIDEA BIOPHARMACEUTICALS, INC.

Company Information

Company Name
NAVIDEA BIOPHARMACEUTICALS, INC.
Address
5600 Blazer Parkway Suite 200
DUBLIN, OH, 43017-7550
Phone
n/a
URL
http://www.navidea.com
DUNS
131891467
Number of Employees
51
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$891,772.00
4
SBIR Phase II
$3,605,134.00
2

Award List

  1. CC49/RIGS, a diagnostic radiopharmaceutical monoclonal antibody, for enhanced liv

    Amount: $315,217.00

    DESCRIPTION (provided by applicant): After an interim period of inactivity based on a select alternative commercial focus, and after consultation with the FDA, Neoprobe Corporation is rapidly reinitia ...

    SBIR Phase I 2012 Department of Health and Human Services
  2. Beta Amyloid Deposits Imaged with 18F-AZD4694 and Postmortem Histology

    Amount: $258,824.00

    DESCRIPTION (provided by applicant): Navidea Biopharmaceuticals is developing 18F-AZD4694 as a diagnostic imaging agent to be used with PET scans to directly visualize beta amyloid (A ) deposits in th ...

    SBIR Phase I 2013 Department of Health and Human Services
  3. A peripheral diagnostic biomarker for Major Depressive Disorder

    Amount: $151,814.00

    DESCRIPTION (provided by applicant): Navidea Biopharmaceuticals is developing [18F]NAV4694 as a diagnostic imaging agent that can be used to visualize beta-amyloid (A) plaques in the brains of living ...

    SBIR Phase I 2013 Department of Health and Human Services
  4. 99mTc-Tilmanocept for Sentinel Lymph Node Biopsy in Cervical Cancer Surgeries

    Amount: $165,917.00

    DESCRIPTION (provided by applicant): Navidea Biopharmaceuticals (Navidea) is seeking SBIR FastTrack grant support to investigate the clinical utility, safety, and efficacy of its new product, 99mTc-ti ...

    SBIR Phase I 2014 Department of Health and Human Services
  5. Beta Amyloid Deposits Imaged with 18F-AZD4694 and Postmortem Histology

    Amount: $1,572,900.00

    DESCRIPTION (provided by applicant): Navidea Biopharmaceuticals is developing 18F-AZD4694 as a diagnostic imaging agent to be used with PET scans to directly visualize beta amyloid (A?) deposits in th ...

    SBIR Phase II 2014 Department of Health and Human Services
  6. [18F]NAV4694 Imaging to Identify MCI Patients at Risk for Alzheimer's Dementia

    Amount: $2,032,234.00

    DESCRIPTION (provided by applicant): Navidea Biopharmaceuticals is developing [18F]NAV4694 as a diagnostic imaging agent that can be used to visualize beta-amyloid (A) plaques in the brains of living ...

    SBIR Phase II 2014 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government